EUCTR2007-003478-25-IT
Active, not recruiting
Not Applicable
?The effect of acute and chronic administration of the CCK1 receptor antagonist Dexloxiglumide (CR2017) on 24-h pH metry, LES motor and symptoms? pattern, in patients with gastroesophageal reflux disease (GERD). A randomized, double-blind, placebo controlled study? - ND
ROTTAPHARM / ROTTA RESEARCH LABORATORIUM0 sitesMarch 6, 2009
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- gastroesaphageal reflux disease (GERD)
- Sponsor
- ROTTAPHARM / ROTTA RESEARCH LABORATORIUM
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- males or female \- age \>\=18 and \<\=70 \- patients with the symptoms of gastroesaphageal reflux disease (GERD) \- heartburn, gastric burning sensation and regurgitation \- according to the following: presence of all the 3 symptoms, regardless of intensity or duration, presence of at least one of the 3 symptoms, with intensity at least moderate or duration at least between 15 and 30 minutes daily \- signed informed consent \- use of contraceptive methods for women of child\-bearing potential
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •\- hiatal hernia \- abdominal surgery \- pregnant or breast\-feeding females \- significant diseases \- use of prohibited medication (among which, H2 blockers and antiacids)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Effects of acute and chronic oral administration of S44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1Catecholaminergic polymorphic ventricular tachycardia type 1MedDRA version: 14.1Level: LLTClassification code 10036095Term: Polymorphic ventricular tachycardiaSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2011-000579-15-GBInstitut de Recherches Internationales Servier36
Active, not recruiting
Not Applicable
Effects of acute and chronic oral administration of S44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1Catecholaminergic polymorphic ventricular tachycardia type 1MedDRA version: 14.1Level: LLTClassification code 10036095Term: Polymorphic ventricular tachycardiaSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2011-000579-15-DEInstitut de Recherches Internationales Servier
Active, not recruiting
Not Applicable
Effects of acute and chronic oral administration of S44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1EUCTR2011-000579-15-FIInstitut de Recherches Internationales Servier
Active, not recruiting
Not Applicable
Effects of acute and chronic oral administration of S44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1EUCTR2011-000579-15-ITINSTITUT DE RECHERCHES INTERNATIONALES SERVIER36
Active, not recruiting
Not Applicable
Effects of acute and chronic oral administration of S44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1Catecholaminergic polymorphic ventricular tachycardia type 1MedDRA version: 14.1Level: LLTClassification code 10036095Term: Polymorphic ventricular tachycardiaSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2011-000579-15-HUInstitut de Recherches Internationales Servier36